Lack of association of IDH1, IDH2 and DNMT3A mutations with outcome in older patients with acute myeloid leukemia treated with hypomethylating agents - PubMed (original) (raw)

doi: 10.3109/10428194.2013.855309. Epub 2014 Feb 4.

Keyur P Patel, Guillermo Garcia-Manero, Rajyalakshmi Luthra, Sherry Pierce, Gautam Borthakur, Elias Jabbour, Tapan Kadia, Naveen Pemmaraju, Marina Konopleva, Stefan Faderl, Jorge Cortes, Hagop M Kantarjian, Farhad Ravandi

Affiliations

• PMID: 24138309
• PMCID: PMC4139917
• DOI: 10.3109/10428194.2013.855309

Lack of association of IDH1, IDH2 and DNMT3A mutations with outcome in older patients with acute myeloid leukemia treated with hypomethylating agents

Courtney D DiNardo et al. Leuk Lymphoma. 2014 Aug.

No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosure: The authors declare no competing financial interest

Figures

Similar articles

• DNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies: associations with prognosis and potential treatment strategies.
  Im AP, Sehgal AR, Carroll MP, Smith BD, Tefferi A, Johnson DE, Boyiadzis M. Im AP, et al. Leukemia. 2014 Sep;28(9):1774-83. doi: 10.1038/leu.2014.124. Epub 2014 Apr 4. Leukemia. 2014. PMID: 24699305 Free PMC article. Review.
• DNMT3A mutations and response to the hypomethylating agent decitabine in acute myeloid leukemia.
  Metzeler KH, Walker A, Geyer S, Garzon R, Klisovic RB, Bloomfield CD, Blum W, Marcucci G. Metzeler KH, et al. Leukemia. 2012 May;26(5):1106-7. doi: 10.1038/leu.2011.342. Epub 2011 Nov 29. Leukemia. 2012. PMID: 22124213 Free PMC article. No abstract available.
• GADD45A methylation predicts poor overall survival in acute myeloid leukemia and is associated with IDH1/2 and DNMT3A mutations.
  Perugini M, Iarossi DG, Kok CH, Cummings N, Diakiw SM, Brown AL, Danner S, Bardy P, Bik To L, Wei AH, Lewis ID, D'Andrea RJ. Perugini M, et al. Leukemia. 2013 Jul;27(7):1588-92. doi: 10.1038/leu.2012.346. Epub 2012 Nov 28. Leukemia. 2013. PMID: 23187294 No abstract available.
• Comparative examination of various PCR-based methods for DNMT3A and IDH1/2 mutations identification in acute myeloid leukemia.
  Berenstein R, Blau IW, Kar A, Cay R, Sindram A, Seide C, Blau O. Berenstein R, et al. J Exp Clin Cancer Res. 2014 May 21;33(1):44. doi: 10.1186/1756-9966-33-44. J Exp Clin Cancer Res. 2014. PMID: 24887327 Free PMC article.
• Perspectives for therapeutic targeting of gene mutations in acute myeloid leukaemia with normal cytogenetics.
  Falini B, Sportoletti P, Brunetti L, Martelli MP. Falini B, et al. Br J Haematol. 2015 Aug;170(3):305-22. doi: 10.1111/bjh.13409. Epub 2015 Apr 19. Br J Haematol. 2015. PMID: 25891481 Review.

Cited by

• Epigenetics in the hematologic malignancies.
  Fong CY, Morison J, Dawson MA. Fong CY, et al. Haematologica. 2014 Dec;99(12):1772-83. doi: 10.3324/haematol.2013.092007. Haematologica. 2014. PMID: 25472952 Free PMC article. Review.
• Management of Newly Diagnosed Acute Myeloid Leukemia in the Elderly: Current Strategies and Future Directions.
  Sanford D, Ravandi F. Sanford D, et al. Drugs Aging. 2015 Dec;32(12):983-97. doi: 10.1007/s40266-015-0309-2. Drugs Aging. 2015. PMID: 26446152 Review.
• Getting personal with myelodysplastic syndromes: is now the right time?
  Chokr N, Pine AB, Bewersdorf JP, Shallis RM, Stahl M, Zeidan AM. Chokr N, et al. Expert Rev Hematol. 2019 Apr;12(4):215-224. doi: 10.1080/17474086.2019.1592673. Epub 2019 Apr 12. Expert Rev Hematol. 2019. PMID: 30977414 Free PMC article. Review.
• Decitabine- and 5-azacytidine resistance emerges from adaptive responses of the pyrimidine metabolism network.
  Gu X, Tohme R, Tomlinson B, Sakre N, Hasipek M, Durkin L, Schuerger C, Grabowski D, Zidan AM, Radivoyevitch T, Hong C, Carraway H, Hamilton B, Sobecks R, Patel B, Jha BK, Hsi ED, Maciejewski J, Saunthararajah Y. Gu X, et al. Leukemia. 2021 Apr;35(4):1023-1036. doi: 10.1038/s41375-020-1003-x. Epub 2020 Aug 7. Leukemia. 2021. PMID: 32770088 Free PMC article.
• 5-Azacitidine in patients with IDH1/2-mutant recurrent glioma.
  Federici L, Capelle L, Annereau M, Bielle F, Willekens C, Dehais C, Laigle-Donadey F, Hoang-Xuan K, Delattre JY, Idbaih A, Lemare F, de Botton S, Sanson M, Touat M. Federici L, et al. Neuro Oncol. 2020 Aug 17;22(8):1226-1228. doi: 10.1093/neuonc/noaa074. Neuro Oncol. 2020. PMID: 32215616 Free PMC article. No abstract available.

References

1. 1. Mardis ER, Ding L, Dooling DJ, Larson DE, McLellan MD, Chen K, et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. The New England journal of medicine. 2009;361(11):1058–66. Epub 2009/08/07. - PMC - PubMed
2. 1. Marcucci G, Maharry K, Wu YZ, Radmacher MD, Mrozek K, Margeson D, et al. IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2010;28(14):2348–55. Epub 2010/04/07. - PMC - PubMed
3. 1. Delhommeau F, Dupont S, Della Valle V, James C, Trannoy S, Masse A, et al. Mutation in TET2 in myeloid cancers. The New England journal of medicine. 2009;360(22):2289–301. Epub 2009/05/29. - PubMed
4. 1. Ernst T, Chase AJ, Score J, Hidalgo-Curtis CE, Bryant C, Jones AV, et al. Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders. Nature genetics. 2010;42(8):722–6. Epub 2010/07/06. - PubMed
5. 1. Ziemin-van der Poel S, McCabe NR, Gill HJ, Espinosa R, 3rd, Patel Y, Harden A, et al. Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias. Proceedings of the National Academy of Sciences of the United States of America. 1991;88(23):10735–9. Epub 1991/12/11. - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • scite Smart Citations

• Medical

  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal